Log In
Print
BCIQ
Print
Print this Print this
 

Neucardin (Recombinant human neuregulin)

  Manage Alerts
Collapse Summary General Information
Company Zensun (Shanghai) Sci. & Tech. Co. Ltd.
DescriptionRecombinant peptide fragment of human neuregulin 1 (rhNRG1)
Molecular Target Neuregulin 1 (NRG1) (HRG1)
Mechanism of Action 
Therapeutic ModalityBiologic: Protein
Latest Stage of DevelopmentRegistration
Standard IndicationHeart failure
Indication DetailsTreat chronic heart failure (CHF)
Regulatory Designation

Partner

SciClone Pharmaceuticals Inc.


 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

$40.5M

0

$28.5M


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury trial today